Asset Details
Do you wish to reserve the book?
The molecular mechanisms of pyroptosis and its implications in tumor immunotherapy
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
The molecular mechanisms of pyroptosis and its implications in tumor immunotherapy
Do you wish to request the book?
The molecular mechanisms of pyroptosis and its implications in tumor immunotherapy
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
The molecular mechanisms of pyroptosis and its implications in tumor immunotherapy
2026
Overview
Pyroptosis is a form of programmed cell death driven by inflammatory caspases (caspase-1/4/5/11). Distinct from apoptosis, pyroptosis is characterized by the formation of membrane pores, cell swelling followed by rupture, and the release of cellular contents, along with the secretion of a wide range of pro-inflammatory cytokines. Pyroptosis can be activated through two primary pathways: the canonical pathway (caspase-1-dependent) and the non-canonical pathway (caspase-4/5/11-dependent). In recent years, the role of pyroptosis in tumor initiation, progression, and therapy has drawn significant attention, revealing its dual regulatory effects—both anti-tumor and tumor-promoting—highlighting its potential as a novel therapeutic target. Given its pivotal role in modulating anti-tumor immunity, the induction of pyroptosis emerges as a promising strategy to enhance the effectiveness of immunotherapy. To date, an increasing number of studies have explored the synergistic potential of combining pyroptosis-inducing strategies with immunotherapy, particularly immune checkpoint blockade, in cancer treatment.This review explores the molecular mechanisms underlying pyroptosis, and systematically summarizes the emerging evidence supporting pyroptosis as an immunogenic form of cell death that enhances immune checkpoint blockade efficacy and offers promising prospects for combination cancer therapies.
Publisher
BioMed Central,Springer Nature B.V,BMC
Subject
